Article ; Online: Using 3% retinol peeling and cosmeceuticals for the aesthetic wellness of the oncological patient after precautionary endocrine treatment: A case series.
Journal of cosmetic dermatology
2023 Volume 23, Issue 1, Page(s) 141–144
Abstract: Background: Roughness, sagging, and skin rash are common in patients with breast cancer treated with LH-RH analog plus tamoxifen or aromatase inhibitors as adjuvant postsurgical endocrine therapy. The use of topical retinol (vitamin A) has shown to be ... ...
| Abstract | Background: Roughness, sagging, and skin rash are common in patients with breast cancer treated with LH-RH analog plus tamoxifen or aromatase inhibitors as adjuvant postsurgical endocrine therapy. The use of topical retinol (vitamin A) has shown to be an efficacious cosmetic treatment. Aims: Peeling with an advanced retinol peel formulation based on 3% retinol, 4% triethyl citrate, 0.1% aminophil, bisabolol, and 1% vitamin E acetate, in a vehicle in an alcoholic solution has been successfully used to ameliorate skin appearance on subjects with photodamage and in the aged population. We aimed to verify its use during adjuvant chemotherapy. Patients: Four subjects experiencing skin issues during postsurgical adjuvant therapy for their breast cancer received retinol peel at least 6 weeks after stopping their postsurgery therapy as a low invasive aesthetic medical treatment to be used both at the dermatology desk and at home. Results: Retinol peel was effective, safe, and well-tolerated, improving skin brightness and firmness in all the patients, since 4 weeks after the beginning of the treatment. Patients declared to be satisfied with the treatment and their skin appearance letting them feel better for cancer recovery, too. Conclusion: These preliminary observations suggest that the use of an advanced retinol peel formulation might improve skin appearance in women experiencing skin damages caused by adjuvant therapy after breast cancer surgery. |
|---|---|
| MeSH term(s) | Female ; Humans ; Aged ; Vitamin A ; Cosmeceuticals/pharmacology ; Skin ; Tamoxifen/adverse effects ; Breast Neoplasms/drug therapy ; Breast Neoplasms/surgery ; Breast Neoplasms/epidemiology |
| Chemical Substances | Vitamin A (11103-57-4) ; Cosmeceuticals ; Tamoxifen (094ZI81Y45) |
| Language | English |
| Publishing date | 2023-07-19 |
| Publishing country | England |
| Document type | Journal Article |
| ZDB-ID | 2280551-5 |
| ISSN | 1473-2165 ; 1473-2130 |
| ISSN (online) | 1473-2165 |
| ISSN | 1473-2130 |
| DOI | 10.1111/jocd.15908 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
| Zs.A 6539: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.